Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Onxeo

Board/Management Information • Nov 15, 2024

1573_iss_2024-11-15_579a52a5-682e-4e73-88dd-4bb793b265fd.pdf

Board/Management Information

Open in Viewer

Opens in native device viewer

Meeting of the Board of Directors of Valerio Therapeutics S.A. on November 13, 2024

At its meeting of November 13, 2024, the Board of Directors of Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), ("Valerio Therapeutics" or the "Company") decided to appoint Mr Julien Miara as CEO and Chairman of the Board of Valerio Therapeutics, succeeding Ms Shefali Argawal, effective immediately.

Future evolutions related to the Company's governance will be announced at a later date.

CONTACTS

Valerio Therapeutics Investor Relations [email protected] France: +33 (0) 1 70 38 33 99 U.S.: +1 617 366 1022

More from Onxeo

Report Publication Announcement 2025
May 6
Report Publication Announcement 2025
May 6
Board/Management Information 2025
Mar 19
Pre-Annual General Meeting Information 2025
Mar 19
Pre-Annual General Meeting Information 2025
Mar 19
Regulatory Filings 2025
Mar 3
Capital/Financing Update 2025
Mar 3
Board/Management Information 2024
Nov 15
Interim / Quarterly Report 2024
Sep 30
Earnings Release 2024
Sep 30
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.